Grupo WP: Widal Pacheco - Endocrimeta - Conte
Grupo WP is a Brazilian clinical laboratory group operating across 22+ cities in Rio Grande do Sul and Santa Catarina through acquired regional brands (Widal Pacheco, Endocrimeta, Conte), providing routine and specialized endocrinology diagnostic testing to patients and health plans.
- Company typePrivate
- Founded2009
- HeadquartersPasso Fundo, Brazil
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Grupo WP: Widal Pacheco - Endocrimeta - Conte does
Grupo WP is a privately held Brazilian clinical laboratory group headquartered in Passo Fundo, Rio Grande do Sul, operating a multi-brand diagnostic testing network across 22+ cities in the southern states of Rio Grande do Sul and Santa Catarina. The group was founded in 2007 around the HORUS laboratory and has grown through a series of acquisitions of established regional laboratories now marketed under the Widal Pacheco, Endocrimeta, and Conte brands, with subsequent geographic extension into the Porto Alegre metropolitan region via the 2023 acquisitions of Endocrimeta and Conte. The company remains controlled by the Dalbosco family, with Rafael Dalbosco having assumed operational leadership in 2016 and the group opening its capital structure to external shareholders in 2018 to finance continued acquisitions.
The group's core offering is routine and specialized clinical laboratory diagnostics — primarily blood and endocrinology testing — delivered through a distributed collection-point network serving individual patients, referring physicians, and health-plan operators across southern Brazil. The portfolio is differentiated by Endocrimeta's specialized endocrinology testing focus, complementing the routine diagnostics performed under the Widal Pacheco and Conte brands. Quality is anchored by DICQ certification across the network, the Brazilian diagnostic-industry quality standard that supports contracting with health plans and referral sources.
The business model is a regional roll-up of clinical laboratories: revenue is generated per test under fee-for-service pricing paid by patients, private health plans, and referring physicians, with group-level consolidation of procurement, quality, and back-office functions creating scale economics over the acquired standalone laboratories. Grupo WP has stated an ambition to be among Brazil's leading clinical laboratory groups by 2027, supported by its continued acquisition cadence since 2013. The group reports 86 employees across its network and maintains a dedicated careers portal to support integration of recent acquisitions.
Grupo WP: Widal Pacheco - Endocrimeta - Conte firmographics
Firmographics- Name
- Grupo WP: Widal Pacheco - Endocrimeta - Conte
- Legal name
- Grupo WP
- Website
- https://grupowp.med.br
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Grupo WP is a Brazilian clinical laboratory group operating across 22+ cities in Rio Grande do Sul and Santa Catarina through acquired regional brands (Widal Pacheco, Endocrimeta, Conte), providing routine and specialized endocrinology diagnostic testing to patients and health plans.
- Ownership category
- akta.pro rank
Grupo WP: Widal Pacheco - Endocrimeta - Conte industry classification
Industry- Product category
- Clinical Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
Keywords
Where Grupo WP: Widal Pacheco - Endocrimeta - Conte is headquartered
LocationHeadquarters
- HQ city
- Passo Fundo
- HQ country
- Brazil
- HQ region
- Latin America
Offices22 records
Markets served
Grupo WP: Widal Pacheco - Endocrimeta - Conte business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Laboratory Testing Services: Laboratory diagnostic services including clinical analysis, blood tests, specialized examinations, and endocrinology testing (Endocrimeta). Revenue generated through patient examinations and tests, likely on a per-test or service basis.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Grupo WP: Widal Pacheco - Endocrimeta - Conte product offering
Product offeringCore offering
Grupo WP operates a multi-brand network of clinical diagnostic laboratories across southern Brazil, delivering routine and specialized medical examinations to individual patients and referring physicians. Its core services include blood tests, clinical analysis, and specialized endocrinology and metabolic testing through the Endocrimeta brand. The group runs more than 22 physical collection and laboratory units in Rio Grande do Sul and Santa Catarina under the Widal Pacheco, Endocrimeta, and Conte brands.
Product overview
Grupo WP is a unified platform consisting of multiple clinical laboratory brands operating across southern Brazil. The portfolio is structured as a platform-plus-sub-brands architecture, comprising Widal Pacheco (the flagship brand formed from the 2017 fusion of Laboratorio Widal and Laboratorio Pacheco), Endocrimeta, and Conte (both acquired in 2023 to expand into Porto Alegre), along with historical acquisitions including HORUS, Jorgens, and Ambrosio laboratories. The group provides clinical laboratory examination services through 23+ locations across Rio Grande do Sul and Santa Catarina states.
Differentiator
Problem solved
Functional benefit
Products and services
- Widal Pacheco Clinical laboratory brand formed from the 2017 merger of Laboratorio Widal (Passo Fundo) and Laboratorio Pacheco (Lages), serving Passo Fundo, Lages, and Serra Catarinense regions with general clinical diagnostic testing services.
- Endocrimeta Clinical laboratory brand acquired in 2023, serving Porto Alegre and metropolitan region with specialization in endocrinology and metabolic testing.
- Conte Clinical laboratory brand acquired in 2023 as part of Grupo WP's expansion into Porto Alegre and the metropolitan region.
Companies that use Grupo WP: Widal Pacheco - Endocrimeta - Conte
Customer profileSegments2 records
Ideal customer profiles2 records
Grupo WP: Widal Pacheco - Endocrimeta - Conte technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Grupo WP: Widal Pacheco - Endocrimeta - Conte partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DICQ - Programa de Certificacao da QualidadecoreDICQ (Programa de Certificação da Qualidade) is a quality certification program for clinical laboratories. The company displays the DICQ certification logo on their website, indicating compliance with quality standards in laboratory operations.
Scale indicators1 record
Recent moves10 records
Expansion highlights5 records
Grupo WP: Widal Pacheco - Endocrimeta - Conte competitors and assessment
Company assessmentRegional players
- Laboratório São Marcos: Established Brazilian clinical laboratory with long-standing regional presence. Comparable in clinical diagnostic service offerings and patient-referral model, though concentrated in different Brazilian regions.
Direct peers
- DB Diagnósticos: Brazilian clinical diagnostics network with multiple units and a similar patient-and-physician go-to-market. Comparable as a regionally concentrated Brazilian lab competitor pursuing consolidation.
- Hermes Pardini: Brazilian clinical analysis laboratory group with strong regional footprint and specialty testing capabilities. Comparable as a mid-sized clinical lab group serving patients and physicians across multiple Brazilian states.
- Grupo Sabin: Brazilian clinical laboratory and diagnostics group with multi-state presence and a similar multi-brand consolidation strategy. Closely comparable in business model and customer base, though operating at larger national scale.
Broad incumbents
- Fleury: Major Brazilian medical diagnostics group with broad clinical lab and imaging services. Comparable as a multi-region, multi-brand clinical lab operator targeting similar patient and physician customers.
- DASA (Diagnósticos da América): Largest clinical diagnostics company in Brazil operating a multi-brand national network of labs and hospitals. Directly comparable as a roll-up acquirer in the same clinical lab market, though materially larger and nationally diversified.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Grupo WP: Widal Pacheco - Endocrimeta - Conte social profiles
Digital presenceGrupo WP: Widal Pacheco - Endocrimeta - Conte compliance and trust
Trust signalCompliance1 record
Grupo WP: Widal Pacheco - Endocrimeta - Conte financial estimates
Financial estimateRevenue estimate
Valuation estimate
Grupo WP: Widal Pacheco - Endocrimeta - Conte leadership team
Management profileNumber of profiles
Profiles10 records
Grupo WP: Widal Pacheco - Endocrimeta - Conte subsidiaries and ownership
Company hierarchySubsidiaries7 records
Grupo WP: Widal Pacheco - Endocrimeta - Conte funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Grupo WP: Widal Pacheco - Endocrimeta - Conte M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Grupo WP: Widal Pacheco - Endocrimeta - Conte
What does Grupo WP: Widal Pacheco - Endocrimeta - Conte do?
Grupo WP operates a multi-brand network of clinical diagnostic laboratories across southern Brazil, delivering routine and specialized medical examinations to individual patients and referring physicians. Its core services include blood tests, clinical analysis, and specialized endocrinology and metabolic testing through the Endocrimeta brand. The group runs more than 22 physical collection and laboratory units in Rio Grande do Sul and Santa Catarina under the Widal Pacheco, Endocrimeta, and Conte brands.
Is Grupo WP: Widal Pacheco - Endocrimeta - Conte a public or private company?
Grupo WP: Widal Pacheco - Endocrimeta - Conte is a private company. It is classified as family owned and is currently operating.
When was Grupo WP: Widal Pacheco - Endocrimeta - Conte founded?
Grupo WP: Widal Pacheco - Endocrimeta - Conte was founded in 2009. It employs 51 to 100 people.
Where is Grupo WP: Widal Pacheco - Endocrimeta - Conte based?
Grupo WP: Widal Pacheco - Endocrimeta - Conte is headquartered in Passo Fundo, Brazil, in the Latin America region.
How does Grupo WP: Widal Pacheco - Endocrimeta - Conte make money?
One revenue line is on record: clinical Laboratory Testing Services.
Who are Grupo WP: Widal Pacheco - Endocrimeta - Conte's main competitors?
Laboratório São Marcos is listed as a regional player. Direct peers are DB Diagnósticos, Hermes Pardini and Grupo Sabin. Broad incumbents are Fleury and DASA (Diagnósticos da América).
Does Grupo WP: Widal Pacheco - Endocrimeta - Conte have an API?
No public API is recorded for Grupo WP: Widal Pacheco - Endocrimeta - Conte.
What industry is Grupo WP: Widal Pacheco - Endocrimeta - Conte in?
Grupo WP: Widal Pacheco - Endocrimeta - Conte's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.